ArticleMolecular therapy. Nucleic acids2021

Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides.

Fumito Wada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.